Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
116 hedge funds and large institutions have $213M invested in Sciclone Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 7 closing their positions.
300% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 7
52% more capital invested
Capital invested by funds: $141M → $213M (+$72.9M)
22% more funds holding
Funds holding: 95 → 116 (+21)
18% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 34
21% less call options, than puts
Call options by funds: $615K | Put options by funds: $778K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.56M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.26M |
| 3 |
Morgan Stanley
New York
|
+$1.82M |
| 4 |
CAM
ClariVest Asset Management
San Diego,
California
|
+$1.72M |
| 5 |
MC
Menta Capital
San Francisco,
California
|
+$1.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$2.44M |
| 2 |
Renaissance Technologies
New York
|
-$1.41M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$875K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$725K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$723K |
SCLN Hedge Fund Activity: Q3 2014 in Review
116 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2014, worth a combined $213M — up 52% from $141M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new SCLN positions and 7 closed out — a net gain of 21 holders — while 40 added to existing stakes and 34 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $4.56M. The largest seller was Franklin Resources, cutting an estimated $2.44M.
- 116 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2014, up from 95 in Q2 2014.
- Funds reported $213M of Sciclone Pharmaceuticals Inc stock for Q3 2014, up 52% quarter-over-quarter.
- 28 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2014 and 7 closed out, a net change of +21 holders.
- The largest Sciclone Pharmaceuticals Inc buyer in Q3 2014 was Acadian Asset Management, an estimated $4.56M added.
- The largest Sciclone Pharmaceuticals Inc seller in Q3 2014 was Franklin Resources, an estimated $2.44M sold.
Based on aggregated 13F filings for Q3 2014.